Newborn screening and disease variants predictneurological outcome in isovaleric aciduria
Abstract: Isovaleric aciduria (IVA), a metabolic disease with severe (classic IVA) or attenuated phenotype (mild IVA), is included in newborn screening (NBS) programs worldwide. The long-term clinical benefit of screened individuals, however, is still rarely investigated. A national, prospective, observational, multi-center study of individuals with confirmed IVA identified by NBS between 1998 and 2018 was conducted. Long-term clinical outcomes of 94 individuals with IVA were evaluated, representing 73.4% (for classic IVA: 92.3%) of the German NBS cohort. In classic IVA (N = 24), NBS prevented untimely death except in one individual with lethal neonatal sepsis (3.8%) but did not completely prevent single (N = 10) or recurrent (N = 7) metabolic decompensations, 13 of them occurring already neonatally. IQ (mean ± SD, 90.7 ± 10.1) was mostly normal but below the reference population (P = .0022) and was even lower in individuals with severe neonatal decompensations (IQ 78.8 ± 7.1) compared to those without crises (IQ 94.7 ± 7.5; P = .01). Similar results were obtained for school placement. In contrast, individuals with mild IVA had excellent neurocognitive outcomes (IQ 105.5 ± 15.8; normal school placement) and a benign disease course (no metabolic decompensation, normal hospitalization rate), which did not appear to be impacted by metabolic maintenance therapy. In conclusion, NBS reduces mortality in classic IVA, but does not reliably protect against severe neonatal metabolic decompensations, crucial for favorable neurocognitive outcome. In contrast, individuals with mild IVA had excellent clinical outcomes regardless of metabolic maintenance therapy, questioning their benefit from NBS. Harmonized stratified therapeutic concepts are urgently needed
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Journal of inherited metabolic disease. - 44, 4 (2021) , 857-870, ISSN: 1573-2665
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- DOI
-
10.1002/jimd.12364
- URN
-
urn:nbn:de:bsz:25-freidok-1942288
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mütze, Ulrike
- Grünert, Sarah
- Spiekerkötter, Ute
- Kölker, Stefan
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Universal newborn hearing screening
Screening for sickle cell disease in newborns: a systematic review
Isovaleric aciduria identified by newborn screening: strategies to predict disease severity and stratify treatment
Economic evaluation of disease detection and management : examples from medical imaging and newborn screening
Genomic newborn screening: are we entering a new era of screening?
Introduction of universal newborn screening for sickle cell disease in Germany - a brief narrative review
Extended newborn screening : Heidelberg, May 30 - June 1, 2008
Methionine adenosyltransferase I/III deficiency detected by newborn screening
Influence of NOD2 variants on Trichuris suis ova treatment outcome in Crohn’s disease
BCL10 deficiency presenting as severe combined immunodeficiency escaping newborn screening
Case report : symptomatic chronic granulomatous disease in the newborn
Progression of lung disease by magnetic resonance imaging and impact of newborn screening in preschool children with cystic fibrosis
Universal newborn hearing screening
Screening for sickle cell disease in newborns: a systematic review
Isovaleric aciduria identified by newborn screening: strategies to predict disease severity and stratify treatment
Economic evaluation of disease detection and management : examples from medical imaging and newborn screening
Genomic newborn screening: are we entering a new era of screening?
Introduction of universal newborn screening for sickle cell disease in Germany - a brief narrative review
Extended newborn screening : Heidelberg, May 30 - June 1, 2008
Methionine adenosyltransferase I/III deficiency detected by newborn screening
Influence of NOD2 variants on Trichuris suis ova treatment outcome in Crohn’s disease
BCL10 deficiency presenting as severe combined immunodeficiency escaping newborn screening
Case report : symptomatic chronic granulomatous disease in the newborn
Progression of lung disease by magnetic resonance imaging and impact of newborn screening in preschool children with cystic fibrosis
Universal newborn hearing screening
Screening for sickle cell disease in newborns: a systematic review
Isovaleric aciduria identified by newborn screening: strategies to predict disease severity and stratify treatment
Economic evaluation of disease detection and management : examples from medical imaging and newborn screening
Genomic newborn screening: are we entering a new era of screening?
Introduction of universal newborn screening for sickle cell disease in Germany - a brief narrative review
Extended newborn screening : Heidelberg, May 30 - June 1, 2008
Methionine adenosyltransferase I/III deficiency detected by newborn screening
Influence of NOD2 variants on Trichuris suis ova treatment outcome in Crohn’s disease
BCL10 deficiency presenting as severe combined immunodeficiency escaping newborn screening
Case report : symptomatic chronic granulomatous disease in the newborn